$SUZ

Suzano (SUZ) boosts Q2 2026 free cash flow to R$3.3B amid higher prices

Suzano S.A. (SUZ) reported 2Q26 Adjusted Free Cash Flow of R$3.3B, up from R$0.6B in 1Q26 and R$2.6B in 2Q25, citing higher prices and stronger volumes. Operating Cash Generation was R$2.9B. The company said net debt at closing was about US$1.0B after a July 1, 2026 closing.

Original reporting
Published Aug 13, 2026, 12:37 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 5:52 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SUZ
Bullish
medium confidence
Mentioned
$SUZ
Relevance
8/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$SUZBullishMed
01

Why it matters

The key tradable takeaway is the magnitude of the free cash flow rebound and the accompanying operating cash generation and leverage metrics, plus the stated drivers (higher prices, stronger volumes, and hedging coverage).

02

Market read

2Q26 cash flow improved materially, with management attributing the move to higher prices and stronger volumes, while also detailing downtime and input-cost/hedging dynamics.

03

What to watch

US operations were impacted by scheduled maintenance downtime and oil-related inputs, so consolidated FCF strength may not be evenly distributed across geographies.

Relevance 8/10Novelty 7/10Timing: 2Q26 results presentation filed Aug 13, 2026

Background

The document is a Form 6-K enclosing Suzano’s 2Q26 earnings conference call presentation and result presentation.

Company-level read

Ticker impact

$SUZBullishMedium confidence
Context

Suzano reported 2Q26 Adjusted Free Cash Flow of R$3.3B, up sharply versus R$0.6B in 1Q26, citing higher prices and volumes.

Expected impact

Likely positive bias for SUZ shares on any follow-through, with volatility tied to pulp/paper pricing and downtime assumptions.

Evidence & confidence

The filing provides concrete cash-flow and operating metrics (free cash flow, cash cost, net debt) and attributes improvement to higher prices and stronger volumes, which are direct drivers of valuation and leverage expectations.

Market effects

Signals improving cash generation in pulp and paper, potentially reinforcing pricing power narratives for the sector.

Brazil-listed issuer disclosure may influence local EM industrial sentiment around commodity-linked earnings quality.

Commodity-linked cash flow and hedging disclosures can affect global pulp/paper risk appetite, especially for investors tracking leverage and FX sensitivity.

Counterpoint

FCF rebound may be partly timing-driven (inventory rebuild, maintenance downtime effects) and could fade if prices or volumes normalize.

Key entities

  • Suzano S.A.

    Brazilian pulp and paper producer filing 2Q26 results via Form 6-K, highlighting Adjusted Free Cash Flow and operating cash generation.

  • Brent

    Used as the reference for oil-related hedging coverage and expected cash adjustments in the presentation.

Related articles

$SUZMed

Suzano Leadership Shake-Up Removes Three Vice-Presidents

Suzano, a Brazilian pulp and paper company, has removed three vice-presidents, including a statutory role, and reorganized executive responsibilities. The changes were approved by the board on 12 August 2026, just before the company's second-quarter earnings release. Suzano reported net revenue of R$ 11.6 billion, adjusted EBITDA of R$ 4.7 billion, and net profit of R$ 1.8 billion for Q2 2026. The company is listed as SUZB3 on B3 and SUZ on the NYSE.

$KMBMed

Arbex Eyes Global Growth With Suzano, Kimberly-Clark

Arbex, the Kleenex tissue maker, told Reuters it plans to add about 10 percentage points of global market share with a new $3.4 billion joint venture involving Suzano after Kimberly-Clark sold a 51% stake in its international tissue business. Arbex aims for 1-2% annual revenue growth and to raise share from 24-25% toward over 35%, investing $100-120m yearly.

$SUZMed

Suzano and Kimberly-Clark Finalize $3.4 Billion JV to Create Arbex

Suzano said it completed its purchase of a 51% stake in FamPro Tissue Holdings B.V. from Kimberly-Clark, forming the Arbex joint venture. Arbex began operations July 1 and will produce and distribute consumer and professional tissue products across 70+ markets. The $3.4B JV includes 22 sites in 14 countries and 40+ brands; Abou-Oaf becomes CEO.

$SUZMedAI 9/10

Suzano (SUZ) Achieves Record Sales Volume of 14.4M Tonnes of Pulp and Paper

Suzano reported record sales in the 12 months ended March, selling 12.7 million tonnes of pulp and 1.7 million tonnes of paper, driven by capacity from its Ribas do Rio Pardo mill and operational efficiency, according to the company. For Q1 2026, it reported 3.2 million tonnes total sales and BRL 11.0 billion net revenue, BRL 4.6 billion adjusted EBITDA, and BRL 4.3 billion net income. Suzano also cited pulp prices above end-2025 expectations and said net debt was $13.0 billion (net leverage 3.3

$TJXMed

Jim Cramer Discussed Ross Stores, Inc. (NASDAQ:ROST) & TJX

Jim Cramer discussed the performance of TJX (NYSE:TJX) and Ross Stores (NASDAQ:ROST), noting their divergent share prices in 2026. TJX is down 8.9% YTD, while Ross Stores is up 30%. Cramer attributed Ross Stores' performance to its CEO, Jim Conroy. TJX reported Q2 earnings, with comparable same-store sales up 4% and raised full-year profit margin guidance to 11.2% and EPS to $4.09-$4.13. Ross Stores reported strong earnings, beating revenue and earnings estimates, with comparable store sales up

$NVDAHighAI 9/10

Whale Rock Just Dumped Most of Its Nvidia Stake

Nvidia reported record Q1 2027 revenue of $81.6B, up 85% YOY, with Data Center revenue rising 92% YOY. Non-GAAP EPS grew 140% YOY to $1.87. Nvidia guided Q2 revenue at ~$91B, excluding China Data Center sales. Whale Rock Capital sold most of its Nvidia stake, but reasons are unclear. Analysts maintain a 'Strong Buy' consensus, with an average price target of $304.32, implying 42% upside.